Chemoinformaics analysis of [(1R,3S)-4-METHYLIDENE-1-PROPAN-2-YL-3-BICYCLO[3.1.0]HEXANYL] ACETATE
| Molecular Weight | 194.274 | nRot | 2 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 19 |
| Exact Molecular Weight | 194.131 | nRing | 2 |
| Solubility: LogS | -5.483 | nHRing | 0 |
| Solubility: LogP | 4.954 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 33.6463 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.677 |
| Synth | 5.622 |
| Natural Product Likeliness | 3.074 |
| NR-PPAR-gamma | 0.082 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.039 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.772 |
| MDCK | 0.0000129 |
| BBB | 0.641 |
| PPB | 0.959505 |
| VDSS | 1.382 |
| FU | 0.0320431 |
| CYP1A2-inh | 0.065 |
| CYP1A2-sub | 0.368 |
| CYP2c19-inh | 0.096 |
| CYP2c19-sub | 0.893 |
| CYP2c9-inh | 0.25 |
| CYP2c9-sub | 0.422 |
| CYP2d6-inh | 0.128 |
| CYP2d6-sub | 0.782 |
| CYP3a4-inh | 0.543 |
| CYP3a4-sub | 0.23 |
| CL | 8.524 |
| T12 | 0.101 |
| hERG | 0.012 |
| Ames | 0.012 |
| ROA | 0.064 |
| SkinSen | 0.117 |
| Carcinogencity | 0.085 |
| EI | 0.884 |
| Respiratory | 0.957 |
| NR-Aromatase | 0.783 |
| Antiviral | No |
| Prediction | 0.605669 |